Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats

Objective: The aim of this study is to prove whether or not the cannabinoid (CB)2 receptor agonist, which is known to be effective in anti-inflammatory effects and tried in various organ and/or tissue ischemia/reperfusion (I/R) injuries, works in the treatment of I/R injury, which is a replication o...

Full description

Bibliographic Details
Main Authors: Ali Parlar, Buket Bilgin Şahin
Format: Article
Language:English
Published: Sakarya University 2019-12-01
Series:Sakarya Tıp Dergisi
Subjects:
Online Access:https://dergipark.org.tr/tr/download/article-file/881658
_version_ 1797350340078600192
author Ali Parlar
Buket Bilgin Şahin
author_facet Ali Parlar
Buket Bilgin Şahin
author_sort Ali Parlar
collection DOAJ
description Objective: The aim of this study is to prove whether or not the cannabinoid (CB)2 receptor agonist, which is known to be effective in anti-inflammatory effects and tried in various organ and/or tissue ischemia/reperfusion (I/R) injuries, works in the treatment of I/R injury, which is a replication of the damage caused by clinical ovarian torsion.Materials and Methods: Rats were divided into five groups (n=6). After anesthesia, an approximately 2-cm incision was made in the lower abdominal region of the rats and both ovaries, uterine horns, and adnexa were occluded with a clamp for 30 min, except for the sham control group. After 3 h, both ovaries were surgically removed. Blood was collected for the measurement of cytokine levels in the serum.Results: The induction of ovaries by I/R injury resulted in an increase in interleukin 1 beta, tumor necrosis factor alpha, and malondialdehyde levels and decrease in glutathione (GSH) levels in ovarian tissues and serum. The pretreatment of the CB2 receptor agonist decreased these cytokines levels in both ovarian tissues and serum. The GSH level in both was reduced by I/R injury, while the agonist increased the GSH level reduced by I/R injury. The administration of the antagonist reversed the curative effect of the agonist. Conclusion: The results of this study support that the CB2 receptor agonist can be used to treat I/R injury, which is an imitation of ovarian torsion. However, no the clinical trial is a limitation of this study.
first_indexed 2024-03-08T12:43:22Z
format Article
id doaj.art-6f807f7a5898452a8583882766314204
institution Directory Open Access Journal
issn 2146-409X
language English
last_indexed 2024-03-08T12:43:22Z
publishDate 2019-12-01
publisher Sakarya University
record_format Article
series Sakarya Tıp Dergisi
spelling doaj.art-6f807f7a5898452a85838827663142042024-01-21T07:40:12ZengSakarya UniversitySakarya Tıp Dergisi2146-409X2019-12-019467968610.31832/smj.62620428Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in RatsAli Parlar0Buket Bilgin Şahin1ADIYAMAN UNIVERSITYADIYAMAN GÖLBAŞI DEVLET HASTANESİObjective: The aim of this study is to prove whether or not the cannabinoid (CB)2 receptor agonist, which is known to be effective in anti-inflammatory effects and tried in various organ and/or tissue ischemia/reperfusion (I/R) injuries, works in the treatment of I/R injury, which is a replication of the damage caused by clinical ovarian torsion.Materials and Methods: Rats were divided into five groups (n=6). After anesthesia, an approximately 2-cm incision was made in the lower abdominal region of the rats and both ovaries, uterine horns, and adnexa were occluded with a clamp for 30 min, except for the sham control group. After 3 h, both ovaries were surgically removed. Blood was collected for the measurement of cytokine levels in the serum.Results: The induction of ovaries by I/R injury resulted in an increase in interleukin 1 beta, tumor necrosis factor alpha, and malondialdehyde levels and decrease in glutathione (GSH) levels in ovarian tissues and serum. The pretreatment of the CB2 receptor agonist decreased these cytokines levels in both ovarian tissues and serum. The GSH level in both was reduced by I/R injury, while the agonist increased the GSH level reduced by I/R injury. The administration of the antagonist reversed the curative effect of the agonist. Conclusion: The results of this study support that the CB2 receptor agonist can be used to treat I/R injury, which is an imitation of ovarian torsion. However, no the clinical trial is a limitation of this study.https://dergipark.org.tr/tr/download/article-file/881658i/ram1241ovarian torsioncytokinesam630i/ram1241ovaryum torsiyonusitokinleram630
spellingShingle Ali Parlar
Buket Bilgin Şahin
Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats
Sakarya Tıp Dergisi
i/r
am1241
ovarian torsion
cytokines
am630
i/r
am1241
ovaryum torsiyonu
sitokinler
am630
title Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats
title_full Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats
title_fullStr Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats
title_full_unstemmed Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats
title_short Protective Effect of Cannabinoid Type 2 Receptor Agonist Against Ovarian Ischemia/reperfusion Injury in Rats
title_sort protective effect of cannabinoid type 2 receptor agonist against ovarian ischemia reperfusion injury in rats
topic i/r
am1241
ovarian torsion
cytokines
am630
i/r
am1241
ovaryum torsiyonu
sitokinler
am630
url https://dergipark.org.tr/tr/download/article-file/881658
work_keys_str_mv AT aliparlar protectiveeffectofcannabinoidtype2receptoragonistagainstovarianischemiareperfusioninjuryinrats
AT buketbilginsahin protectiveeffectofcannabinoidtype2receptoragonistagainstovarianischemiareperfusioninjuryinrats